Upcoming Changes to Medicare Prescription Drug Costs

Older adults using Medicare prescription drug coverage might face higher monthly expenses in 2027. This follows the end of a temporary subsidy program by the Trump administration. The Centers for Medicare & Medicaid Services (CMS) announced the conclusion of the program initially set up by the Biden administration in 2024. This program aimed to reduce Medicare Part D drug costs, responding to the 2022 Inflation Reduction Act’s effects.

The government claims the financial impact on beneficiaries will be minor. However, the decision may have political ramifications, especially with the midterm elections approaching. Cost of living concerns many voters, especially older adults who typically have fixed incomes. About 25 million Americans with Medicare Part D plans will learn about their 2027 rates in the fall during election season.

Democrats condemned the move, viewing it as a pattern of reducing healthcare affordability. Senate Minority Leader Chuck Schumer criticized the administration on social media, accusing them of raising costs unnecessarily for seniors.

CMS Administrator Dr. Mehmet Oz explained that ending the subsidy program would save billions of taxpayer dollars from going to insurance companies. The program cost approximately $3.6 billion in 2026. He noted that most beneficiaries would see an increase of under $10 per month, and some might even experience lower premiums. Efforts to reduce prescription drug prices will continue, including access to affordable plans and specific medications.

The federal government also directly negotiates with drug companies to lower Medicare costs for certain expensive drugs, following a program created by Congress in 2022. The recent decision does not affect the out-of-pocket cap for standalone Medicare drug coverage, which limits yearly expenses for prescriptions to $2,100 by 2026, with a rise to $2,400 expected in 2027.

In 2023, Medicare Part D beneficiaries, with the subsidies, paid an average of $36 monthly for drug premiums. The average subsidy reduced premiums by $16 in 2026. The precise impact of the changes on beneficiaries remains uncertain, but CMS will share information about 2024 premiums in September.

Juliette Cubanski from the healthcare research nonprofit KFF mentioned that price hikes could be modest for some but significant for others, especially when paired with rising costs in groceries, gas, and housing. “The key concern is how the monthly budget balances,” she stated. “For some, it might become more challenging to manage expenses.”